Package 60505-3883-7

{"route": ["ORAL"], "spl_id": "e5459b2b-579f-6e7f-91a9-23ee61f86399", "openfda": {"nui": ["N0000190856", "N0000190855"], "unii": ["Z9O08YRN8O"], "rxcui": ["199592", "805464"], "spl_set_id": ["471ac1d8-e3ad-7729-87c5-c26ae92c32eb"], "pharm_class_epc": ["Vesicular Monoamine Transporter 2 Inhibitor [EPC]"], "pharm_class_moa": ["Vesicular Monoamine Transporter 2 Inhibitors [MoA]"], "manufacturer_name": ["Apotex Corp."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "112 TABLET in 1 BOTTLE (60505-3883-7)", "package_ndc": "60505-3883-7", "marketing_start_date": "20200618"}], "brand_name": "Tetrabenazine", "product_id": "60505-3883_e5459b2b-579f-6e7f-91a9-23ee61f86399", "dosage_form": "TABLET", "pharm_class": ["Vesicular Monoamine Transporter 2 Inhibitor [EPC]", "Vesicular Monoamine Transporter 2 Inhibitors [MoA]"], "product_ndc": "60505-3883", "generic_name": "tetrabenazine", "labeler_name": "Apotex Corp.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Tetrabenazine", "active_ingredients": [{"name": "TETRABENAZINE", "strength": "25 mg/1"}], "application_number": "ANDA206093", "marketing_category": "ANDA", "marketing_start_date": "20200618", "listing_expiration_date": "20261231"}